Amexdrug Corp (OTC Pink - Limited Information:AXRX.PK)

0.102
Delayed Data
As of Apr 23
 0.00 / 0.00%
Today’s Change
0.04
Today|||52-Week Range
0.30
-57.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues8.6M8.9M9.3M10.4M
 
 
 
 
 
Cost of Goods Sold7.5M7.8M7.7M8.5M
 
 
 
 
 
Depreciation And Amortization10.8K9.2K7.9K7.4K
 
 
 
 
 
 
Operating ExpensesGross Income1.1M1.1M1.6M2.0M
 
 
 
 
 
General Expenses921.1K915.0K1.5M1.7M
 
 
 
 
 
Research And Development0.000.0037.5K69.2K
 
 
 
Total Operating Expenses8.5M8.7M9.2M10.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income154.0K168.4K145.6K214.6K
 
 
 
 
 
Extraordinary Credit103.000.000.004.6K
 
 
 
Extraordinary Charge---298.00-1.2K0.00
 
 
 
Interest Expense On Debt28.5K17.6K33.0K51.3K
 
 
 
 
 
Other Expenses-9.8K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income115.9K150.6K111.4K168.1K
 
 
 
 
 
Income Taxes-39.4K-50.3K-37.7K-56.8K
 
 
 
 
 
Net Income76.5K100.3K73.8K111.4K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS169.4M169.4M169.4M169.4M
 
 
 
 
 
Shares To Calculate EPS Diluted169.4M169.4M169.4M169.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.00$0.00$0.00--
EPS Diluted$0.00$0.00$0.00$0.00